• +91 882 525 4416
  • bd@essentialmarketinsights.com
  • Pune, MH, India

September 2020 | PDF | 178 Pages | Biologics | Recombinant DNA | Pharmaceuticals | Market Research

Global Recombinant Protein Market Analysis (2015-19), By Product (Hormones, Cytokines, Plasma Protein Factor, Growth Factors, Recombinant Metabolic Enzymes and Others); Application (Drug Discovery & Development, Biopharmaceutical Production, and Others); End User (Biopharmaceutical Companies, Academic & Research Institutes, Contract Research Organizations and Others) and Forecasting (2020-2025)

Market Outlook, Growth Perspectives, Regional Markets, Value Chain Analysis, Competitive Analysis, Company Profiles

Project Overview



Recombinant protein is an engineered form of a natural protein, produced in several approaches to modifying gene sequences, increasing the production of proteins, and manufacturing useful commercial products. Recombinant proteins are generally used to produce antibodies & enzymes for disease treatment, pharmaceutical products, protein-based polymers for drug delivery, protein scaffolds for tissue engineering, and among others. This manipulated protein is not only used in biomedical research but also utilized in food production, agriculture, and bioengineering and treatment, like drugs. In the clinic, recombinant proteins include recombinant hormones (interleukins & interferons), tumor necrosis factors, growth factors, blood clotting factors, enzymes & thrombolytic drugs for treating major diseases such as diabetes, dwarfism, congestive heart failure, multiple sclerosis, neutropenia, anemia, hepatitis, rheumatoid arthritis, asthma, Crohn’s disease, cancer therapies, and others.

Recombinant human insulin was the first recombinant protein used in the treatment, in 1982, and since, the RP industry is rapidly growing.


Growth Factors


Recombinant Proteins For Biotherapeutics : Several human diseases, namely hemophilia, cancer, diabetes, infectious diseases, and anemia, are related to the dysfunction of specific proteins for providing therapy treatments. Majorly RP vaccines are approved vaccines by FDA is the Hepatitis B vaccine for the prevention of the infection by the Hepatitis B virus. For clinical purposes, more than 130 RP vaccines are approved by FDA, and 170 RP vaccines are produced in medicine till the date, worldwide. Currently, most big pharma companies are focusing on developing RP as drugs, and hence, the industry is growing significantly.

Advancements In Biotechnology :  In the biotechnology field, the growing advancements have facilitated and lifted the production of recombinant proteins for various applications, including diagnostic reagents, therapeutic drugs, and basic life science research.

Role of Recombinant Proteins in Biomedical Research : Recombinant proteins played a vital role in understanding the protein-protein interactions, which is a crucial section of cellular processes. Currently, RP microarrays are becoming widespread in examining protein-protein interactions. The method is more prevalent in scientists in the study of the protein interactions, with other peptides or proteins, small molecules, enzymes, lipids, and nucleic acids. Thus, owing to the factors mentioned above, the recombinant proteins help to upsurge more opportunities in biomedical research.


Emerging Spots


Geography: Asia Pacific is a very lucrative market for recombinant proteins since it holds almost XX of the overall market with a growth rate of XX% PA. Affordability, increase in chronic diseases, push for growing research-oriented programs, growing applications in genetics & therapeutics, etc. are some of the reasons why this region is seeing huge increase in the recombinant proteins market.


  • Updates

Many companies in APAC are exploring an increase in approvals and exports to the EU and the US. Some recent updates include the following:

• In July 2020, a Bengaluru-based biotechnology company Richcore LifeSciences has expanded its manufacturing capabilities by building its second recombinant protein manufacturing facility in Tumkur, Karnataka.

LakePharma, Inc., a US-based biologics CRDMO has launched GMP manufacturing of recombinant proteins and antibodies with TunaCHO and CHO-GSN platforms at Hayward, California facility, in April 2019.




Companies covered in this section include Lonza, GenScript, Merck & Co., Inc., Eli Lilly and Company, 7TM Antibodies, NOVOPROTEIN SCIENTIFIC INC., BPS Bioscience, Inc., Crown Bioscience Inc., REPROCELL USA Inc. and Thermo Fisher Scientific Inc.



Recombinant Proteins Market can be segmented into the following:


By Products

• Hormones

         • Cytokines

• Plasma Protein Factor

• Growth Factors

• Recombinant Metabolic Enzymes

• Others


By Production Type

• cGMP



By Application

• Drug Discovery & Development

• Biopharmaceutical Production

• Others


By End User

• Biopharmaceutical Companies

• Contract Research Organization

• Academic & Research Institutes

• Others


By Region

North America

• US

• Canada


• UK

• Germany

• France

• Spain

• Italy

• Russia

• Others


• India

• China

• S.Korea

• Japan

• Australia

• Others


• Mexico

• Brazil

• Argentina

• Chile

• Peru

• Others

Africa and Middle East

• Israel

• Turkey

• Egypt

• Saudi Arabia

• South Africa

• Others

To get a copy of Table of Contents (ToC), Report Blue Print or Sample Copy please Click HERE

To get a copy of List of Deliverables please share your requirements HERE

We offer customized reports as per our customers requirements. This covers a 360 degree deliverable scope study such as:

  • You may need some additional insights in MARKET RESEARCH report as per your decision making team. Please let us know your requirements.
  • You may require a SOURCING INTELLIGENCE report for this topic as per requirement for your sourcing/procurement teams. You may let us know your requirements and we will prepare a feasibility study for your perusal.
  • You may require a hybrid report consisting of Market Research Data and Sourcing Intelligence inputs in one report. Please let us know your requirement and we will share the list of deliverables for this Market Intelligence.
  • You may require an Extensive and Potential List of Suppliers or Potential List of Customers Or List of other Stakeholders. Please feel to let us know and we will share the scope study.

This section covers very brief quick reports as a scale down version of original Market Research report. You may be any of the following:

  • You may require market data in a quick interval of time, and you don’t have further need.
  • You are a research scholar and you need market research in brief for some project
  • Due to budget constraints you may need market research report in brief

Please don’t worry and write to us HERE

For any other discussion such as related to various reports, future business requirements, feasibility discussion, etc. Or for talk to our sales team executive please feel free to reach out to us HERE

Related Projects

Global Oncology/Cancer Biosimilars Market

North America Biosimilars Market

Europe Biosimilars Market

Global Biosimilars Insulin Market

contact us

We are here to help you




+91 882 525 4416